NCT04016090

Brief Summary

The purpose of this study is to evaluate if folic acid improves endothelial sensitivity to shear stress in post-menopausal women.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2019

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 3, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

July 11, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

September 9, 2019

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 3, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 3, 2024

Completed
Last Updated

December 12, 2024

Status Verified

December 1, 2024

Enrollment Period

4.6 years

First QC Date

July 3, 2019

Last Update Submit

December 9, 2024

Conditions

Keywords

Postmenopausal womenVascular healthFolic acid

Outcome Measures

Primary Outcomes (1)

  • Endothelial sensitivity to shear rate

    Change in brachial artery diameter for given levels of shear rate during rhythmic handgrip exercise

    Measured 2 hours after placebo or folic acid consumption

Secondary Outcomes (1)

  • Neurovascular transduction

    Measured 2 hours after placebo or folic acid consumption

Study Arms (2)

Placebo treatment

PLACEBO COMPARATOR

Participant will be asked to ingest a placebo capsule.

Other: Placebo

Folic Acid

EXPERIMENTAL

Participant will be asked to ingest a capsule containing 5 mg of folic acid.

Dietary Supplement: Folic Acid

Interventions

Folic AcidDIETARY_SUPPLEMENT

Folic acid (5 mg)

Folic Acid
PlaceboOTHER

Placebo capsule

Placebo treatment

Eligibility Criteria

Age50 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 1-year amenorrhea
  • Body mass index ≤ 30 kg/m2
  • Resting blood pressure \< 140 / \< 90 mmHg
  • Non-smoker (≥ 1-year)

You may not qualify if:

  • Diagnosis of cardiac, vascular, respiratory, neurological or metabolic disease and/or a prescription of medications for the treatment of such diseases.
  • For female participants, hormonal replacement therapy within 1 year of enrolment in the study.
  • For female participants, having undergone an ovariectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cardiovascular Prevention and Rehabilitation Centre of the Montreal Heart Institute

Montreal, Quebec, H1T1N6, Canada

Location

MeSH Terms

Interventions

Folic Acid

Intervention Hierarchy (Ancestors)

PterinsPteridinesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic Compounds

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

July 3, 2019

First Posted

July 11, 2019

Study Start

September 9, 2019

Primary Completion

April 3, 2024

Study Completion

April 3, 2024

Last Updated

December 12, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

All individual data will be de-identified and available to the public through publications, media articles and conference presentations

Locations